Lexaria Bioscience Corp

NASDAQ:LEXX  
1.19
+0.12 (+11.22%)
7:53:47 PM EDT: $1.19 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)23.28M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.14 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$1.02
50-Day MA$0.90
200-Day MA$1.39
See more pivots

Lexaria Bioscience Corp Stock, NASDAQ:LEXX

740 McCurdy Road, Suite 100, Kelowna, British Columbia V1X 2P7
Canada
Phone: +1.250.765.6424
Number of Employees: 7

Description

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.